Variant report
Variant | esv1831815 |
---|---|
Chromosome Location | chr11:18978785-18993133 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:39)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:39 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr11:18985505-18985506 | K562 | blood: | n/a | n/a |
2 | CHD2 | chr11:18980168-18980255 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CTCF | chr11:18980266-18980292 | Fibrobl | skin: | n/a | n/a |
4 | CTCF | chr11:18980219-18980331 | GM19239 | blood: | n/a | n/a |
5 | CTCF | chr11:18980237-18980331 | GM19240 | blood: | n/a | n/a |
6 | CTCF | chr11:18980224-18980331 | GM19238 | blood: | n/a | n/a |
7 | CTCF | chr11:18980230-18980333 | Hela-S3 | cervix: | n/a | n/a |
8 | CTCF | chr11:18989550-18989639 | GM20000 | blood: | n/a | n/a |
9 | CTCF | chr11:18980222-18980312 | ProgFib | skin: | n/a | n/a |
10 | CTCF | chr11:18980239-18980330 | K562 | blood: | n/a | n/a |
11 | CTCF | chr11:18980226-18980331 | GM12892 | blood: | n/a | n/a |
12 | CTCF | chr11:18980221-18980332 | Gliobla | brain: | n/a | n/a |
13 | CTCF | chr11:18980265-18980298 | NHEK | skin: | n/a | n/a |
14 | CTCF | chr11:18980240-18980312 | MCF-7 | breast: | n/a | n/a |
15 | CTCF | chr11:18980230-18980320 | MCF-7 | breast: | n/a | n/a |
16 | CTCF | chr11:18980222-18980331 | GM12891 | blood: | n/a | n/a |
17 | CTCF | chr11:18980237-18980329 | A549 | lung: | n/a | n/a |
18 | CTCF | chr11:18980233-18980333 | HepG2 | liver: | n/a | n/a |
19 | CTCF | chr11:18980259-18980264 | Fibrobl | skin: | n/a | n/a |
20 | E2F4 | chr11:18986196-18986375 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | GATA3 | chr11:18981100-18981298 | SH-SY5Y | brain: | n/a | n/a |
22 | MAFK | chr11:18986291-18986350 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | MAFK | chr11:18985121-18985260 | HepG2 | liver: | n/a | n/a |
24 | MAFK | chr11:18981378-18981467 | HepG2 | liver: | n/a | n/a |
25 | MAFK | chr11:18981296-18981506 | HepG2 | liver: | n/a | n/a |
26 | MYC | chr11:18986312-18986489 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | MYC | chr11:18988153-18988230 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr11:18980950-18981058 | GM12878 | blood: | n/a | n/a |
29 | POLR2A | chr11:18980245-18980302 | H1-hESC | embryonic stem cell: | n/a | n/a |
30 | POLR2A | chr11:18980107-18980595 | H1-hESC | embryonic stem cell: | n/a | n/a |
31 | POLR2A | chr11:18993050-18993328 | H1-neurons | neurons: | n/a | n/a |
32 | POLR2A | chr11:18983140-18983207 | MCF-7 | breast: | n/a | n/a |
33 | SP1 | chr11:18979974-18980395 | H1-hESC | embryonic stem cell: | n/a | n/a |
34 | SPI1 | chr11:18991356-18991659 | HL-60 | blood: | n/a | chr11:18991516-18991529 |
35 | TCF12 | chr11:18980074-18980368 | H1-hESC | embryonic stem cell: | n/a | n/a |
36 | TEAD4 | chr11:18979945-18980539 | H1-hESC | embryonic stem cell: | n/a | n/a |
37 | TEAD4 | chr11:18980071-18980437 | ECC-1 | luminal epithelium: | n/a | n/a |
38 | TEAD4 | chr11:18979944-18980437 | H1-hESC | embryonic stem cell: | n/a | n/a |
39 | YY1 | chr11:18980095-18980420 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000254738 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540204829 | chr11:18978813-18978814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73432553 | chr11:18978825-18978826 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs377101471 | chr11:18978837-18978838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533624438 | chr11:18978993-18978994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6483558 | chr11:18979001-18979002 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs570143729 | chr11:18979029-18979030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs578032747 | chr11:18979053-18979054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139185723 | chr11:18979086-18979087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6483559 | chr11:18979090-18979091 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs12284674 | chr11:18979111-18979112 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs534815556 | chr11:18979114-18979115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546033657 | chr11:18979152-18979153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs147105109 | chr11:18979153-18979154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552904565 | chr11:18979164-18979165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147464856 | chr11:18979171-18979172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182961084 | chr11:18979194-18979195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557270265 | chr11:18979199-18979200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575324183 | chr11:18979201-18979202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542772696 | chr11:18979268-18979269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7117865 | chr11:18979344-18979345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554825409 | chr11:18979359-18979360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572927386 | chr11:18979378-18979379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs116474273 | chr11:18979395-18979396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564862846 | chr11:18979401-18979402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs118131912 | chr11:18979402-18979403 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs148083102 | chr11:18979420-18979421 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564040937 | chr11:18979424-18979425 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75512429 | chr11:18979443-18979444 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531127910 | chr11:18979489-18979490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549140280 | chr11:18979491-18979492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2007021 | chr11:18979540-18979541 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs5790055 | chr11:18979561-18979562 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200763667 | chr11:18979567-18979568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528526169 | chr11:18979585-18979586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528637641 | chr11:18979589-18979590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187548908 | chr11:18979590-18979591 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539052643 | chr11:18979596-18979597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs111498926 | chr11:18979606-18979607 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370760184 | chr11:18979610-18979611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374011720 | chr11:18979611-18979612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569105212 | chr11:18979667-18979668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536157561 | chr11:18979670-18979671 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540465987 | chr11:18979689-18979690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12792588 | chr11:18979703-18979704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573113928 | chr11:18979708-18979709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12285022 | chr11:18979711-18979712 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs558710199 | chr11:18979714-18979715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532871635 | chr11:18979745-18979746 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12285066 | chr11:18979793-18979794 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs563932235 | chr11:18979858-18979859 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Lung cancer | 17086460 | CNVD |
Uterine serous papillary cancer | 19536090 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:18974800-18979400 | Weak transcription | NHEK | skin |
2 | chr11:18975000-18979600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr11:18978600-18979000 | Enhancers | H9 Cell Line | embryonic stem cell |
4 | chr11:18979000-18979400 | Weak transcription | H9 Cell Line | embryonic stem cell |
5 | chr11:18979400-18979600 | Enhancers | H9 Cell Line | embryonic stem cell |
6 | chr11:18979400-18980000 | Enhancers | NHEK | skin |
7 | chr11:18979400-18980800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
8 | chr11:18979400-18981000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr11:18979400-18981000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr11:18979400-18981200 | Enhancers | HMEC | breast |
11 | chr11:18979400-18981400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr11:18979600-18980800 | Weak transcription | H9 Cell Line | embryonic stem cell |
13 | chr11:18979600-18981200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr11:18979800-18980600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr11:18979800-18980600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr11:18979800-18981000 | Enhancers | H1 Cell Line | embryonic stem cell |
17 | chr11:18979800-18981000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
18 | chr11:18980000-18980400 | Flanking Active TSS | NHEK | skin |
19 | chr11:18980400-18981400 | Enhancers | NHEK | skin |
20 | chr11:18980600-18981000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
21 | chr11:18980800-18981200 | Enhancers | H9 Cell Line | embryonic stem cell |
22 | chr11:18984800-18993200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |